Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Iodobenzamide for in vivo exploration of central dopamine receptors: Evaluation in animal models of supersensitivity

Journal Article · · Life Sciences; (USA)
; ; ; ; ; ;  [1];  [2];  [3]
  1. INSERM U316, Tours (France)
  2. INSERM U259, Bordeaux (France)
  3. Compagnie ORIS Industrie, Gif-sur-Yvette (France)

Iodobenzamide is a promising agent to investigate D{sub 2} receptors by SPECT in living human brain. In this work, we have evaluated this radiolabeled compound in two animal models of D{sub 2} receptors supersensitivity. In the first model, rats were treated chronically with haloperidol during three weeks (S.C. injection of 0.5 mg/kg/day). One week after the last day of treatment, they were I.V. injected with {sup 125}I-IBZM. In vivo specific binding study showed a 45 percent increase of {sup 125}I-IBZM fixation in the striatum of treated rats. In a second step of experiments, animals were unilaterally lesioned by a stereotaxic injection of 6-OHDA in the substantia nigra, 23 days before receiving {sup 125}I-IBZM. Autoradiographic analysis of coronal brain sections showed a 38 percent enhancement of {sup 125}I-IBZM in vivo binding in the striatum on the lesioned side as compared to the controlateral intact side; this increase occurred in striatal lateral area. These data demonstrate that {sup 125}I-IBZM is convenient to detect alterations of dopamine D{sub 2} receptors in vivo in the rat. Thus IBZM labelled with {sup 123}I can be a very useful imaging agent for the exploration of D{sub 2} receptors in pathological situations.

OSTI ID:
6528964
Journal Information:
Life Sciences; (USA), Journal Name: Life Sciences; (USA) Vol. 47:8; ISSN 0024-3205; ISSN LIFSA
Country of Publication:
United States
Language:
English

Similar Records

Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra
Journal Article · Thu Feb 28 23:00:00 EST 1991 · Experimental Neurology; (USA) · OSTI ID:5962655

In vitro and in vivo evaluation of (/sup 123/I)IBZM: a potential CNS D-2 dopamine receptor imaging agent
Journal Article · Sat Dec 31 23:00:00 EST 1988 · J. Nucl. Med.; (United States) · OSTI ID:6406676

( sup 125 I)(+)FISCH: A new CNS D-1 dopamine receptor imaging ligand
Journal Article · Sat Dec 31 23:00:00 EST 1988 · Life Sciences; (USA) · OSTI ID:6968640